Who is sponsoring NCT06885411?

NCT06885411 is sponsored by Reinier Haga Orthopedisch Centrum.

What drugs are being tested in NCT06885411?

Interventions in NCT06885411: metal-on-metal hip arthroplasty.

What condition does NCT06885411 study?

NCT06885411 studies Ototoxic Hearing Loss, Cobalt Poisoning, Chromium Causing Toxic Effect, Arthroplasty Complications.

Is NCT06885411 still recruiting?

NCT06885411 is currently recruiting now. Last updated 20 March 2025.

Last reviewed 2025-03-20 · How we verify

NCT06885411: GODMOTHER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ototoxicity in Patients With MoM Hip Bearings

Recruiting now Last updated 20 March 2025

What this trial tests

trial testing metal-on-metal hip arthroplasty in Ototoxic Hearing Loss in 200 participants. Currently enrolling.

Timeline

1 February 2023

Primary endpoint
1 December 2025

1 December 2025

Quick facts

Lead sponsor	Reinier Haga Orthopedisch Centrum
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 February 2023
Primary completion	1 December 2025
Estimated completion	1 December 2025
Sites	1 location across Netherlands

Drugs / interventions tested

metal-on-metal hip arthroplasty

Conditions studied

Ototoxic Hearing Loss — all drugs for Ototoxic Hearing Loss →
Cobalt Poisoning — all drugs for Cobalt Poisoning →
Chromium Causing Toxic Effect — all drugs for Chromium Causing Toxic Effect →
Arthroplasty Complications — all drugs for Arthroplasty Complications →

Sponsor

Reinier Haga Orthopedisch Centrum

Who can join

Eligibility, any sex, with Ototoxic Hearing Loss or Cobalt Poisoning. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about ototoxicity in patients with a MoM hip arthroplasty. The main question it aims to answer is: • What is the prevalence of hearing loss in patients with high and low plasma metal concentrations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Reinier Haga Orthopedisch Centrum trials

Trials by the same sponsor.

NCT07070570 — HAKA: Routine Follow-up at 10 Years After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare? · NA · not yet recruiting
NCT06654349 — Short-term Recovery After Trapeziectomy and TMC Prosthesis: a Diary Study · recruiting
NCT06275776 — HIP-STITCH (Wound Recovery After THA) · NA · recruiting
NCT06327217 — Long Term Results After Hip Arthroscopy · unknown
NCT05638386 — Effect of Plugging the Registration Pin Tract in Robotic-assisted Knee Surgery · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06885411 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Reinier Haga Orthopedisch Centrum
Last refreshed: 20 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06885411.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing